
|Articles|April 10, 2003
Phase III shaping up - Enrollment completed in final CK clinical trial
Irvine, CA-Refractec Inc. has completed patient enrollment for its phase III clinical trial for conductive keratoplasty (CK) as a treatment for presbyopia.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement

















